The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
(10 - 33) Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.20 - Manufacture of pharmaceutical preparations
207 jobs Number of planned job losses
Announcement Date
12 November 2019
Employment effect (start)
1 January 2020
Foreseen end date
Description
The pharmaceutical group MSD has announced a restructuring of its Riom site (Puy-de-Dôme) with 207 job cuts planned. Specialised in the manufacture and packaging of sterile medicines, including eye drops and antibiotics, the plant is one of the main French and even European sites of the American pharmaceutical giant, Merck Sharp & Dohme (MSD).
In addition to the reorganisation, the group has also announced that it is looking for a buyer for this site. This reorganisation is expected to run in two phases. First, a closure of the site's laboratories because, according to the managment, the number of toxicology studies entrusted to the research centre has decreased considerably in recent years. The MSD group is therefore now considering discontinuing this activity. This research centre currently employs 106 people.
Second, the production part would be restructured. In the long term, 101 jobs could be lost in production if this project reaches its target. The reorganisation is now subject to an information-consultation and negotiation process with the site's employee representative bodies, the first meeting of which is scheduled on 20 November 2019.
A previous reorganisation announcement took place in 2014 (385 job cuts) at the MSD French headquarter.
Eurofound (2019), Merck Sharp & Dohme Chibret, Internal restructuring in France, factsheet number 99114, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/99114.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...
The more employee monitoring resembles surveillance – with its systematic, continuous and detailed tracking of employees' activities, behaviours or communications – the greater the potential for infringement of both privacy and data protection rights. Although the EU General Data Protection...
Since 2013, Eurofound's ERM database on restructuring-related legislation has been documenting regulatory developments in the Member States of the European Union and Norway which are explicitly or implicitly linked to anticipating and managing change. The most recent update to the...